北美血管成形术球囊市场 – 行业趋势及 2029 年预测

血管成形术球囊市场的市场分析和见解

预计血管成形术球囊市场将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析该市场在上述预测期内的复合年增长率为 1.4%。

血管成形术球囊（也称为经皮腔内血管成形术）基本上是一种微创血管内手术，用于打开狭窄或阻塞的动脉或静脉以治疗动脉粥样硬化。它使用连接到导管的球囊，将导管插入动脉，然后在斑块沉积物变窄或关闭血流通道的同一位置充气。血管成形术球囊有不同类型，包括普通球囊血管成形术、药物涂层球囊 (DCB) 血管成形术、切割球囊、刻划球囊和支架移植球囊导管，它们广泛应用于各种终端用途，如心导管室、医院、专科诊所、门诊手术中心和诊断中心。

The growing number of increase in the incidence of cardiovascular diseases with heart diseases becoming a major cause of fatalities along with increase in the geriatric population in both developed and developing countries and are the significant factors responsible for driving the growth of the angioplasty balloons market in the above-mentioned forecast period. Moreover, the factors such as various technological advancements, increasing healthcare expenditure and increasing preference for minimally invasive procedures as compared to conventional surgeries, the various benefits of minimally invasive surgeries such as reduced surgical pain, injury, scarring, hospital stay, higher accuracy, and speedy recovery time are encouraging more patients to opt for minimally invasive balloon angioplasty surgeries are estimated to boost the market’s growth. Additionally, the growing incidence of target disease and the favorable government policies and increasing coronary and peripheral interventions also heighten the overall growth of the market. On the other hand, the factors such as high costs associated with the procedure coupled with stiffness of the device are estimated to obstruct the market’s growth in the forecast period of 2022 to 2029. The high investment in research and development is also one of the restraint that hampers the overall growth of the market.

Furthermore, the growing awareness created by medical professionals and key players about the benefits of angioplasty balloons and increasing technological advancements and incorporation of innovation in the industry are expected to generate profitable opportunities for the market. On the flip side, the complications associated with angioplasty procedures obstruct the market’s growth and have the potential to challenge for the market’s growth.

This angioplasty balloons market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research angioplasty balloons market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Angioplasty Balloons Market Scope and Market Size

血管成形术球囊市场根据类型、材料、 球囊 类型、疾病适应症和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概况和市场洞察，帮助他们做出战略决策，确定核心市场应用。

• 根据类型，血管成形术球囊市场分为普通老式球囊血管成形术、药物涂层球囊 (DCB) 血管成形术、切割球囊、刻划球囊和支架移植物球囊导管。
• 根据材料，血管成形术球囊市场分为尼龙、聚氨酯、 硅酮 聚氨酯共聚物和其他。
• 根据球囊类型，血管成形术球囊市场分为半顺应性球囊和非顺应性球囊。
• 根据疾病指征，血管成形术球囊市场分为冠状动脉成形术、静脉血管成形术、颈动脉血管成形术、 肾 动脉血管成形术和外周血管成形术。
• 根据最终用户，血管成形术球囊市场分为心导管实验室、 医院、专科诊所、门诊手术中心和诊断中心。

血管成形术球囊 市场国家级分析

对血管成形术球囊市场进行了分析，并按类型、材料、球囊类型、疾病指征和最终用户提供了市场规模洞察和趋势。

血管成形术球囊市场报告涵盖的国家包括北美的美国、加拿大和墨西哥。

由于众多制药公司和生物技术公司的普及，以及 2022 年至 2029 年预测期内该国良好的医疗设施，美国在血管成形术球囊行业占据主导地位。

血管成形术球囊市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀少的竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

血管成形术球囊市场还为您提供每个国家/地区资本设备医疗支出增长、血管成形术球囊市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对血管成形术球囊市场的影响的详细市场分析。数据涵盖 2010 年至 2020 年的历史时期。

竞争格局和血管成形术球囊 市场份额分析

血管成形术球囊市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对血管成形术球囊市场的关注有关。

血管成形术球囊市场报告中的一些主要参与者包括美敦力、BD、波士顿科学公司、雅培、AngioDynamics、B. Braun Melsungen AG.、Biomerics、BIOTRONIK、Cook、Cardinal Health、Hexacath、JOTEC GmbH、CTK biotech, Inc、Koninklijke Philips NV.、微创医疗科学公司、Panmed Health-care、Nipro Medical Corporation、Palex Medical、Stryker、Teleflex Incororated 和 Terumo Corporation 等。

SKU-24530